916 related articles for article (PubMed ID: 18397619)
1. [Should patients with chronic renal insufficiency be treated with folic acid, vitamin B6 and vitamin B12?].
Birn H
Ugeskr Laeger; 2008 Mar; 170(11):933-7. PubMed ID: 18397619
[TBL] [Abstract][Full Text] [Related]
2. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
3. Effect of folic acid, vitamin B6 and vitamin B12 supplementation on mortality and cardiovascular complication among patients with chronic kidney disease: an evidence-based case report.
Nursalim A; Siregar P; Widyahening IS
Acta Med Indones; 2013 Apr; 45(2):150-6. PubMed ID: 23770797
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study.
Mann JF; Sheridan P; McQueen MJ; Held C; Arnold JM; Fodor G; Yusuf S; Lonn EM;
Nephrol Dial Transplant; 2008 Feb; 23(2):645-53. PubMed ID: 18003666
[TBL] [Abstract][Full Text] [Related]
5. [Nutritional medicine 2007].
Hauner H
Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1411-3. PubMed ID: 17570092
[No Abstract] [Full Text] [Related]
6. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
[TBL] [Abstract][Full Text] [Related]
7. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
8. [Group B vitamins as new variables related to the cardiovascular risk].
Granieri M; Bellisarii FI; De Caterina R
Ital Heart J Suppl; 2005 Jan; 6(1):1-16. PubMed ID: 15776726
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
[TBL] [Abstract][Full Text] [Related]
10. [The effect of lowering plasma homocysteine levels on some parameters of thrombotic activity in haemodialyzed patients with chronic renal failure].
Kozłowska I
Ann Acad Med Stetin; 2004; 50(1):87-95. PubMed ID: 16871747
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
[TBL] [Abstract][Full Text] [Related]
12. Effect of folate, vitamin B6, and vitamin B12 intake and MTHFR C677T polymorphism on homocysteine concentrations of renal transplant recipients.
Biselli PM; Sanches de Alvarenga MP; Abbud-Filho M; Ferreira-Baptista MA; Galbiatti AL; Goto MT; Cardoso MA; Eberlin MN; Haddad R; Goloni-Bertollo EM; Pavarino-Bertelli EC
Transplant Proc; 2007 Dec; 39(10):3163-5. PubMed ID: 18089344
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine lowering and cardiovascular events after acute myocardial infarction.
Bønaa KH; Njølstad I; Ueland PM; Schirmer H; Tverdal A; Steigen T; Wang H; Nordrehaug JE; Arnesen E; Rasmussen K;
N Engl J Med; 2006 Apr; 354(15):1578-88. PubMed ID: 16531614
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of lipoprotein(a) and homocysteine in patients on hemodialysis who take hydroxymethylglutaryl-CoA reductase inhibitors, vitamin B6, and folic acid.
Shojaei MH; Djalali M; Siassi F; Khatami MR; Boroumand MA; Eshragian MR
Iran J Kidney Dis; 2009 Jul; 3(3):141-4. PubMed ID: 19617662
[TBL] [Abstract][Full Text] [Related]
15. [Hyperhomocysteinemia as a vascular risk factor in chronic hemodialysis patients].
Trimarchi H; Young P; Díaz ML; Schropp J; Forrester M; Freixas E
Medicina (B Aires); 2005; 65(6):513-7. PubMed ID: 16433478
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine, fibrinogen, and lipoprotein(a) levels are simultaneously reduced in patients with chronic renal failure treated with folic acid, pyridoxine, and cyanocobalamin.
Naruszewicz M; Klinke M; Dziewanowski K; Staniewicz A; Bukowska H
Metabolism; 2001 Feb; 50(2):131-4. PubMed ID: 11229418
[TBL] [Abstract][Full Text] [Related]
17. [No scientific evidence supports vitamin B treatment of patients with cardiovascular diseases].
Ekstedt B; Jansson JH; Boman K
Lakartidningen; 2006 Nov 8-14; 103(45):3464-6. PubMed ID: 17140177
[No Abstract] [Full Text] [Related]
18. Folic acid 5 or 15 mg/d similarly reduces plasma homocysteine in patients with moderate-advanced chronic renal failure.
Bernasconi AR; Liste A; Del Pino N; Rosa Diez GJ; Heguilén RM
Nephrology (Carlton); 2006 Apr; 11(2):137-41. PubMed ID: 16669976
[TBL] [Abstract][Full Text] [Related]
19. Hyperhomocysteinemia in a cohort of young patients with acute myocardial infarction from Western India: pattern of response to oral folic acid, vitamin B12, B6 therapy.
Ghosh K; Khare A; Shetty S; Kulkarni B
Clin Chim Acta; 2007 Feb; 377(1-2):281-2. PubMed ID: 17069780
[No Abstract] [Full Text] [Related]
20. Vitamin B6 metabolism and homocysteine in end-stage renal disease and chronic renal insufficiency.
Lindner A; Bankson DD; Stehman-Breen C; Mahuren JD; Coburn SP
Am J Kidney Dis; 2002 Jan; 39(1):134-45. PubMed ID: 11774112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
